Reply to the letter to the editor "Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19 association does not mean causality."

Nicolas Dauby; Lucy Catteau; Joris Hautekiet; Marion Montourcy; Emmanuel Bottieau; Els Goetghebeur; Dominique Van Beckhoven

doi:10.1016/j.ijantimicag.2020.106261

Reply to the letter to the editor "Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19 association does not mean causality."

Nicolas Dauby, Lucy Catteau, Joris Hautekiet, Marion Montourcy, Emmanuel Bottieau, Els Goetghebeur, Dominique Van Beckhoven

Tropical Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	106261
Journal	International Journal of Antimicrobial Agents
Volume	57
Issue number	2
Number of pages	2
ISSN	0924-8579
DOIs	https://doi.org/10.1016/j.ijantimicag.2020.106261
Publication status	Published - 2021

Keywords

Azithromycin
COVID-19/drug therapy
Coronavirus Infections
Humans
Hydroxychloroquine/therapeutic use
SARS-CoV-2

Access to Document

10.1016/j.ijantimicag.2020.106261

Cite this

Dauby, N., Catteau, L., Hautekiet, J., Montourcy, M., Bottieau, E., Goetghebeur, E., & Van Beckhoven, D. (2021). Reply to the letter to the editor "Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19 association does not mean causality.". International Journal of Antimicrobial Agents, 57(2), [106261]. https://doi.org/10.1016/j.ijantimicag.2020.106261

Dauby, Nicolas ; Catteau, Lucy ; Hautekiet, Joris ; Montourcy, Marion ; Bottieau, Emmanuel ; Goetghebeur, Els ; Van Beckhoven, Dominique. / Reply to the letter to the editor "Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19 association does not mean causality.". In: International Journal of Antimicrobial Agents. 2021 ; Vol. 57, No. 2.

@article{18c29716ab364cdba3c5424aea1f2224,

title = "Reply to the letter to the editor {"}Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19 association does not mean causality.{"}",

keywords = "Azithromycin, COVID-19/drug therapy, Coronavirus Infections, Humans, Hydroxychloroquine/therapeutic use, SARS-CoV-2",

author = "Nicolas Dauby and Lucy Catteau and Joris Hautekiet and Marion Montourcy and Emmanuel Bottieau and Els Goetghebeur and {Van Beckhoven}, Dominique",

note = "NPP; OGOA",

year = "2021",

doi = "10.1016/j.ijantimicag.2020.106261",

language = "English",

volume = "57",

journal = "International Journal of Antimicrobial Agents",

issn = "0924-8579",

publisher = "Elsevier",

number = "2",

}

Dauby, N, Catteau, L, Hautekiet, J, Montourcy, M, Bottieau, E, Goetghebeur, E & Van Beckhoven, D 2021, 'Reply to the letter to the editor "Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19 association does not mean causality."', International Journal of Antimicrobial Agents, vol. 57, no. 2, 106261. https://doi.org/10.1016/j.ijantimicag.2020.106261

Reply to the letter to the editor "Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19 association does not mean causality.". / Dauby, Nicolas; Catteau, Lucy; Hautekiet, Joris; Montourcy, Marion; Bottieau, Emmanuel; Goetghebeur, Els; Van Beckhoven, Dominique.

In: International Journal of Antimicrobial Agents, Vol. 57, No. 2, 106261, 2021.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Reply to the letter to the editor "Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19 association does not mean causality."

AU - Dauby, Nicolas

AU - Catteau, Lucy

AU - Hautekiet, Joris

AU - Montourcy, Marion

AU - Bottieau, Emmanuel

AU - Goetghebeur, Els

AU - Van Beckhoven, Dominique

N1 - NPP; OGOA

PY - 2021

Y1 - 2021

KW - Azithromycin

KW - COVID-19/drug therapy

KW - Coronavirus Infections

KW - Humans

KW - Hydroxychloroquine/therapeutic use

KW - SARS-CoV-2

U2 - 10.1016/j.ijantimicag.2020.106261

DO - 10.1016/j.ijantimicag.2020.106261

M3 - Letter

C2 - 33321211

VL - 57

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 2

M1 - 106261

ER -